Albuquerque Journal
By Scott Sandlin
… According to the lawsuit:
Janssen got FDA approval to market Risperdal oral tablets for the treatment of schizophrenia in 1993 and for variations to treat bipolar disorder in 2003. But the drug has shown a propensity for its users to gain weight, have movement disorders and other health problems, including diabetes.
Since its [...]
